Cart
sales@molnova.com
API-1
CAS No. 36707-00-3
API-1( NSC177223 )
Catalog No. M24326 CAS No. 36707-00-3
API-1 is a potent inhibitor of Akt. It induces GSK3-dependent, β-TrCP- and FBXW7-mediated Mcl-1 degradation, resulting in induction of apoptosis .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 128 | In Stock |
|
| 5MG | 121 | In Stock |
|
| 10MG | 207 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 770 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAPI-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAPI-1 is a potent inhibitor of Akt. It induces GSK3-dependent, β-TrCP- and FBXW7-mediated Mcl-1 degradation, resulting in induction of apoptosis .
-
DescriptionAPI-1 is a potent inhibitor of Akt. It induces GSK3-dependent, β-TrCP- and FBXW7-mediated Mcl-1 degradation, resulting in induction of apoptosis .
-
In Vitro——
-
In Vivo——
-
SynonymsNSC177223
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36707-00-3
-
Formula Weight337.29
-
Molecular FormulaC13H15N5O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1=C(C(=O)C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ren H , Koo J , Guan B , et al. The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis[J]. Molecular Cancer, 2013, 12(1):146-146.
molnova catalog
related products
-
Ipatasertib dihydroc...
Ipatasertib dihydrochloride is a highly selective and ATP-competitive inhibitor of pan-Akt (IC50s: 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively).
-
CYNARIN
CYNARIN is a natural product. It shows antioxidant and choleretic properties and is a potential immunosuppressive agent.
-
AT7867
AT7867 is a potent, ATP-competitive, orally available dual Akt and p70S6K inhibitor with Ki of 17-85 nM, also inhibits PKA with Ki of 20 nM.
